These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 18580477)

  • 1. Increased donor CD86+CD14+ cells in the bone marrow and peripheral blood of patients with chronic graft-versus-host disease.
    Arpinati M; Chirumbolo G; Marzocchi G; Baccarani M; Rondelli D
    Transplantation; 2008 Jun; 85(12):1826-32. PubMed ID: 18580477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Origin and subset distribution of peripheral blood dendritic cells in patients with chronic graft-versus-host disease.
    Clark FJ; Freeman L; Dzionek A; Schmitz J; McMullan D; Simpson P; Mason J; Mahendra P; Craddock C; Griffiths M; Moss PA; Chakraverty R
    Transplantation; 2003 Jan; 75(2):221-5. PubMed ID: 12548127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute graft-versus-host disease and steroid treatment impair CD11c+ and CD123+ dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation.
    Arpinati M; Chirumbolo G; Urbini B; Bonifazi F; Bandini G; Saunthararajah Y; Zagnoli A; Stanzani M; Falcioni S; Perrone G; Tura S; Baccarani M; Rondelli D
    Biol Blood Marrow Transplant; 2004 Feb; 10(2):106-15. PubMed ID: 14750076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association with the presence of naive T cells in chronic myeloid leukemia patients after allogeneic human stem cell transplantation and the lower incidence of chronic graft-versus host disease and relapse.
    Wysoczanska B; Bogunia-Kubik K; Dlubek D; Jaskula E; Sok A; Drabczak-Skrzypek D; Sedzimirska M; Lange A
    Transplant Proc; 2007 Nov; 39(9):2898-901. PubMed ID: 18022011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher numbers of blood CD14+ cells before starting conditioning regimen correlate with greater risk of acute graft-versus-host disease in allogeneic stem cell transplantation from related donors.
    Arpinati M; Chirumbolo G; Saunthararajah Y; Stanzani M; Bonifazi F; Bandini G; Baccarani M; Rondelli D
    Biol Blood Marrow Transplant; 2007 Feb; 13(2):228-34. PubMed ID: 17241928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor.
    Jun HX; Jun CY; Yu ZX
    Haematologica; 2004 Dec; 89(12):1517-24. PubMed ID: 15590404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease.
    Balon J; Hałaburda K; Bieniaszewska M; Reichert M; Bieniaszewski L; Piekarska A; Pawłowski R; Hellmann A
    Bone Marrow Transplant; 2005 Jun; 35(11):1083-8. PubMed ID: 15821766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The functional immaturity of dendritic cells can be relevant to increased tolerance associated with cord blood transplantation.
    Encabo A; Solves P; Carbonell-Uberos F; Miñana MD
    Transfusion; 2007 Feb; 47(2):272-9. PubMed ID: 17302774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Sanchez J; Casaño J; Alvarez MA; Roman-Gomez J; Martin C; Martinez F; Gomez P; Serrano J; Herrera C; Torres A
    Br J Haematol; 2004 Sep; 126(5):697-703. PubMed ID: 15327522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reconstitution dynamics of plasmacytoid and myeloid dendritic cell precursors after allogeneic HLA mismatched/ haploidentical hematopoietic stem cell transplantation].
    Wu JY; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):73-7. PubMed ID: 17650664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered Toll-like receptor 9 responses in circulating B cells at the onset of extensive chronic graft-versus-host disease.
    She K; Gilman AL; Aslanian S; Shimizu H; Krailo M; Chen Z; Reid GS; Wall D; Goldman F; Schultz KR
    Biol Blood Marrow Transplant; 2007 Apr; 13(4):386-97. PubMed ID: 17382246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated numbers of immature/transitional CD21- B lymphocytes and deficiency of memory CD27+ B cells identify patients with active chronic graft-versus-host disease.
    Greinix HT; Pohlreich D; Kouba M; Körmöczi U; Lohmann I; Feldmann K; Zielinski C; Pickl WF
    Biol Blood Marrow Transplant; 2008 Feb; 14(2):208-19. PubMed ID: 18215781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predominant infiltration of monocytes in chronic graft-versus-host disease.
    Namba N; Shinagawa K; Fujii N; Maeda Y; Ishimaru F; Ikeda K; Matsui T; Tanimoto M; Katayama Y
    Transplantation; 2007 Jan; 83(2):220-4. PubMed ID: 17264819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation.
    Pavletic SZ; Smith LM; Bishop MR; Lynch JC; Tarantolo SR; Vose JM; Bierman PJ; Hadi A; Armitage JO; Kessinger A
    Am J Hematol; 2005 Apr; 78(4):265-74. PubMed ID: 15795914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential analysis of HLA-C-specific killer cell inhibitory receptor (CD158b) expressing peripheral blood mononuclear cells during chronic graft-versus-host disease.
    Tanaka J; Tutumi Y; Mori A; Ohta S; Kobayashi S; Asaka M; Imamura M
    Bone Marrow Transplant; 2000 Aug; 26(3):287-90. PubMed ID: 10967567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased interleukin 10 and increased interferon-gamma production in patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Körholz D; Kunst D; Hempel L; Söhngen D; Heyll A; Bönig H; Göbel U; Zintl F; Burdach S
    Bone Marrow Transplant; 1997 Apr; 19(7):691-5. PubMed ID: 9156246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated circulating dendritic cells after hematopoietic stem cell transplantation predict acute graft-versus-host disease.
    Lau J; Sartor M; Bradstock KF; Vuckovic S; Munster DJ; Hart DN
    Transplantation; 2007 Apr; 83(7):839-46. PubMed ID: 17460553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimerism does not influence graft-versus-myeloma and graft-versus-host disease in reduced intensity setting.
    Galimberti S; Benedetti E; Morabito F; Fazzi R; Pacini S; Andreazzoli F; Martino M; Iacopino P; Petrini M
    Transpl Immunol; 2005 Dec; 15(2):173-7. PubMed ID: 16412962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor cell reaction to OKT3 as predictor of chronic graft-vs-host disease in hematopoietic stem cell recipients.
    Lindemann M; Ottinger HD; Elmaagacli AH; Trenschel R; Rebmann V; Beelen DW; Grosse-Wilde H
    Exp Hematol; 2006 Dec; 34(12):1753-8. PubMed ID: 17157173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmacytoid dendritic cell count on day 28 in HLA-matched related allogeneic peripheral blood stem cell transplant predicts the incidence of acute and chronic GVHD.
    Rajasekar R; Mathews V; Lakshmi KM; Sellathamby S; George B; Viswabandya A; Daniel D; Chandy M; Srivastava A
    Biol Blood Marrow Transplant; 2008 Mar; 14(3):344-50. PubMed ID: 18275901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.